Yearly Archives: 2016
How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?
With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It
“Troubleshooting” a Key Challenge of the Global Branding Process for New Bio-Pharma Products: Alignment Across Geographies
In the bio-pharmaceutical industry, it is no secret that different regions of the world have diverse regulatory and cultural environments. What is less apparent is that given these regional regulatory and cultural differences, pharmaceutical companies can have an effective global
Digital Consortium Meeting Identifies Top Mobile Engagement Approaches, including Unbranded Video, Patient Logbooks & Disease State Information Tools
Mobile tools have become an integral part of digital marketing for the bio-pharmaceutical industry. Health care companies have turned to mobile applications in particular to provide resources, services and critical references for customers. According to our latest benchmark research: Digital
Pharma Executive Talks Timing, Targeting and Trouble for Disease State Awareness Campaigns
In the pharmaceutical sector, disease state awareness campaigns are one of the few ways to reach patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch. While
Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?
Recently, I was reading Luca Dezzani’s article “Patient Engagement: A Key Element in Pharmaceutical Marketing Strategy.” The article prompted me to think about how pharma companies continue to think about and discuss the idea of Patient Engagement, and ultimately what
Building Regulatory Affairs: Efficiency Quadrant that Drives Spend
Best Practices, LLC has recently completed “Benchmarking Regulatory Affairs Staffing & Performance Excellence in Medical Devices,” a new operational benchmarking study. After analyzing the data and probing the experience of 30 regulatory affairs (RA) organizations from large and complex companies
5 Important Trends Shaping Pharma Business in 2016
In a sector as fast-changing as biopharmaceuticals, it’s important to look beyond today’s hot topics to identify the long-term factors which are really driving change in the industry. From a list that could include a hundred headline-grabbing trends, we’ve pinned